One of the state pharmaceutical companies, partially
privatized on the stock exchange.
Manufacturing of cosmetics & 56 pharmaceutical lines, with exports to Middle Eastern, African & Eastern European markets.
Highest market share among public companies.
Plans to open Middle East's first genetic engineering facility to produce specialty drugs.
Plans for manufacturing TAMONILE for birds flu treatment.
Negotiating with Sanofi Aventis to obtain 5 new licenses.
Expanding its activity with 3 new production lines in beverages.